- Home
- TOVX vs PALI Comparison
TOVX vs PALI Comparison
Compare TOVX & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- PALI
- Stock Information
- Founded
- TOVX 2001
- PALI 1996
- Country
- TOVX United States
- PALI United States
- Employees
- TOVX N/A
- PALI N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOVX Health Care
- PALI Health Care
- Exchange
- TOVX Nasdaq
- PALI Nasdaq
- Market Cap
- TOVX 3.5M
- PALI 3.5M
- IPO Year
- TOVX 2006
- PALI N/A
- Fundamental
- Price
- TOVX $1.21
- PALI $1.85
- Analyst Decision
- TOVX Strong Buy
- PALI Strong Buy
- Analyst Count
- TOVX 1
- PALI 2
- Target Price
- TOVX $6.00
- PALI $23.00
- AVG Volume (30 Days)
- TOVX 102.1K
- PALI 3.7M
- Earning Date
- TOVX 11-12-2024
- PALI 11-12-2024
- Dividend Yield
- TOVX N/A
- PALI N/A
- EPS Growth
- TOVX N/A
- PALI N/A
- EPS
- TOVX N/A
- PALI N/A
- Revenue
- TOVX N/A
- PALI N/A
- Revenue This Year
- TOVX N/A
- PALI N/A
- Revenue Next Year
- TOVX N/A
- PALI N/A
- P/E Ratio
- TOVX N/A
- PALI N/A
- Revenue Growth
- TOVX N/A
- PALI N/A
- 52 Week Low
- TOVX $1.14
- PALI $1.38
- 52 Week High
- TOVX $17.00
- PALI $22.35
- Technical
- Relative Strength Index (RSI)
- TOVX 37.37
- PALI 41.13
- Support Level
- TOVX $1.15
- PALI $1.59
- Resistance Level
- TOVX $1.34
- PALI $2.20
- Average True Range (ATR)
- TOVX 0.07
- PALI 0.38
- MACD
- TOVX 0.01
- PALI 0.02
- Stochastic Oscillator
- TOVX 7.41
- PALI 19.80
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.